ArticleMedicina (Kaunas, Lithuania)2024

Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk.

Renata Rajtar-Salwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.